Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Eye Drops & Ophthalmic Recalls

Recalls of ophthalmic solutions and eye drops - a category hit by widely reported contamination recalls.

673 recalls in this category, newest first.

Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class II · Moderate risk

Brinzolamide Ophthalmic Suspension

Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.

Terminated Packaging defect Teva Pharmaceuticals USA NDC 0591-2127-79 D-0373-2022
Class II · Moderate risk

Mvasi

Lack of Assurance of Sterility

Terminated Sterility / contamination Edge Pharma, LLC NDC 05446-1661-13 D-0412-2022
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022
Class II · Moderate risk

Betaxolol Ophthalmic Solution

Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

Terminated Microbial contamination Akorn, Inc. NDC 17478-705-11 D-0004-2022